| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A dose–response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
|
Atmar, Robert L.
|
|
2007
|
25 |
29 |
p. 5367-5373
7 p.
|
article
|
| 2 |
Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands
|
Bults, M.
|
|
2007
|
25 |
29 |
p. 5272-5277
6 p.
|
article
|
| 3 |
Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy
|
Lao-araya, Mongkol
|
|
2007
|
25 |
29 |
p. 5324-5329
6 p.
|
article
|
| 4 |
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults
|
Kester, Kent E.
|
|
2007
|
25 |
29 |
p. 5359-5366
8 p.
|
article
|
| 5 |
Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children
|
Esposito, Susanna
|
|
2007
|
25 |
29 |
p. 5283-5289
7 p.
|
article
|
| 6 |
“Bible”'s new version
|
Sadighi Akha, Amir A.
|
|
2007
|
25 |
29 |
p. 5441-5442
2 p.
|
article
|
| 7 |
Editorial Board
|
|
|
2007
|
25 |
29 |
p. CO2-
1 p.
|
article
|
| 8 |
Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques
|
Koraka, Penelopie
|
|
2007
|
25 |
29 |
p. 5409-5416
8 p.
|
article
|
| 9 |
Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen
|
Mullen, Gregory E.D.
|
|
2007
|
25 |
29 |
p. 5343-5347
5 p.
|
article
|
| 10 |
Enhancement of IFN-γ production for Th1-cell therapy using negatively charged liposomes containing phosphatidylserine
|
Yotsumoto, Satoshi
|
|
2007
|
25 |
29 |
p. 5256-5262
7 p.
|
article
|
| 11 |
Enteric fever due to Salmonella typhi and paratyphi A
|
Wilde, Henry
|
|
2007
|
25 |
29 |
p. 5246-5247
2 p.
|
article
|
| 12 |
Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine
|
Shakya, Krishna P.
|
|
2007
|
25 |
29 |
p. 5374-5377
4 p.
|
article
|
| 13 |
Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies
|
Hu, R.L.
|
|
2007
|
25 |
29 |
p. 5301-5307
7 p.
|
article
|
| 14 |
Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens
|
Gómez, Sara
|
|
2007
|
25 |
29 |
p. 5263-5271
9 p.
|
article
|
| 15 |
Guillain–Barre syndrome after vaccination in United States
|
Souayah, Nizar
|
|
2007
|
25 |
29 |
p. 5253-5255
3 p.
|
article
|
| 16 |
Herd immunity and pneumococcal conjugate vaccine: A quantitative model
|
Haber, Michael
|
|
2007
|
25 |
29 |
p. 5390-5398
9 p.
|
article
|
| 17 |
Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis
|
Moreno, J.
|
|
2007
|
25 |
29 |
p. 5290-5300
11 p.
|
article
|
| 18 |
Immunogenicity of reduced antigen content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine
|
Zepp, Fred
|
|
2007
|
25 |
29 |
p. 5248-5252
5 p.
|
article
|
| 19 |
Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes
|
Houghton, Colin S.B.
|
|
2007
|
25 |
29 |
p. 5330-5342
13 p.
|
article
|
| 20 |
Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology
|
Cyr, Sonya L.
|
|
2007
|
25 |
29 |
p. 5378-5389
12 p.
|
article
|
| 21 |
Pneumococcal vaccine concerns: Shape-shifters and beyond
|
Singh, Nishith K.
|
|
2007
|
25 |
29 |
p. 5244-5245
2 p.
|
article
|
| 22 |
Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease
|
Hsieh, Ming Kun
|
|
2007
|
25 |
29 |
p. 5417-5427
11 p.
|
article
|
| 23 |
Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine
|
Smets, F.
|
|
2007
|
25 |
29 |
p. 5278-5282
5 p.
|
article
|
| 24 |
Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model
|
Negi, Vidya Devi
|
|
2007
|
25 |
29 |
p. 5315-5323
9 p.
|
article
|
| 25 |
Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies
|
Rezaei, Nima
|
|
2007
|
25 |
29 |
p. 5308-5314
7 p.
|
article
|
| 26 |
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
|
Brisson, Marc
|
|
2007
|
25 |
29 |
p. 5399-5408
10 p.
|
article
|
| 27 |
TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces
|
Chabot, Sophie M.
|
|
2007
|
25 |
29 |
p. 5348-5358
11 p.
|
article
|
| 28 |
Trends in influenza immunisation amongst an elderly Australian community
|
Gill, Tiffany K.
|
|
2007
|
25 |
29 |
p. 5428-5432
5 p.
|
article
|
| 29 |
Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis
|
De Wals, Philippe
|
|
2007
|
25 |
29 |
p. 5433-5440
8 p.
|
article
|
| 30 |
WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1–2 June 2006
|
Ferguson, Morag
|
|
2007
|
25 |
29 |
p. 5233-5243
11 p.
|
article
|
Journal description